Drug Profile
Research programme: vaccines for ophthalmic diseases - OncoTherapy Science/Shionogi
Alternative Names: Peptide vaccines for ophthalmic diseases - OncoTherapy Science/ShionogiLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator OncoTherapy Science
- Developer OncoTherapy Science; Shionogi
- Class Subunit vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Eye disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Eye-disorders in Japan (Ophthalmic)
- 06 Dec 2010 Early research in Eye disorders in Japan (Ophthalmic)